NA Proactive news snapshot: CytoDyn, NexTech AR Solutions, Nabis Holdings, Mota Ventures …

NA Proactive news snapshot: CytoDyn, NexTech AR Solutions, Nabis Holdings, Mota Ventures …

Proactive Investors

Published

CytoDyn Inc (OTCMKTS:CYDY) told investors it was looking for potential partners to study its lead drug leronlimab for treating the spreading killer coronavirus, which broke out in China and has now claimed 106 lives. Coronavirus is the name for a large family of viruses, some causing illness in people and others that circulate in animals. The 2019 Novel Coronavirus (2019-nCoV) has been identified as the cause of an outbreak of the respiratory illness first detected in the city of Wuhan in China. NexTech AR Solutions Corp (OTCMKTS:NEXCF) (CSE:NTAR) is partnering with Jolokia, an enterprise video platform provider to the healthcare industry, to bring augmented reality (AR) to interactive training videos. Jolokia’s platform, known as Inferno, is an online training and learning experience platform that can support healthcare clients that require integration with enterprise systems, custom workflow, cognitive search and discovery, translation and accessibility, interactive video and secure multi-CDN streaming. Nabis Holdings Inc (CSE:NAB) (OTCMKTS:NABIF), a Canadian cannabis investment company, revealed Tuesday that it has struck a binding memorandum of understanding with Panaxia Pharmaceutical Industries Ltd, the largest medical cannabis products maker in Israel. Under the terms of the pact, Panaxia will provide proprietary pharma-grade cannabis-based products that have proven to be in high demand in other states in the US, including New Mexico, Colorado and California. Mota Ventures Corp (CSE:MOTA) (OTCMKTS:PEMTF) announced a new agreement Tuesday that gives the firm access to Canada’s largest live genetic cannabis library. The Vancouver-based company signed a licensing and royalty agreement with Phenome One Corporation, a private genetic and seed preservation company with over 350 cultivars and access to around 1,700 unique genetics in its seed bank. Under the terms of the deal, Mota has the right to propagate, cultivate, harvest and process at least 10 selected cultivars from Phenome’s genetic library and to sell anything it produces from the selections. Seelos Therapeutics Inc (NASDAQ:SEEL) announced the formation of an in-vivo study of its Parkinson’s Disease program SLS-007, the company’s second gene therapy approach for Parkinson’s Disease. The plan is to utilize an Adeno-Associated Virus (AAV) as a delivery vector, and Seelos is currently producing the viral vector and preparing animals for the study.  Co-Diagnostics Inc (NASDAQ:CODX) CEO Dwight Egan spoke with CNBC Squawk Box Asia about the importance and challenges of creating a high-quality diagnostic test to detect the deadly coronavirus that originated in China. The Salt Lake City-based company has completed the principle design work for a genetic screening test to detect the disease, which has propelled Co-Diagnostics and its stock into the spotlight. The coronavirus has already killed more than 100 people.  Ximen Mining Corp (CVE:XIM) (OTCMKTS:XXMMF) has expanded its footprint in the Nelson and Greenwood areas of British Columbia with the acquisition of new claims.  The Vancouver-based firm has bought 100% interests in the California Gold Nelson mineral claim in the Nelson camp, and the CMM mineral claim in the Camp McKinney gold camp from a private individual, it said in a statement. CB2 Insights Inc (CSE:CBII) (OTMKTS:CBIIF), the cannabis research and education group, said Tuesday that it has completed its payment obligations for its acquisition of New Jersey Alternative Medicine last June.  According to the terms of the deal, the Canadian company will issue 2.5 million shares to be escrowed over 15 months, with a rolling release over the term. The purchase payout will amount to roughly $800,000 and CB2 Insights will now see an approximate savings of $440,000 The Flowr Corporation (CVE:FLWR) (OCTMKTS:FLWPF) has realigned its leadership "to drive operational and financial efficiencies", the firm told investors on Tuesday. The cannabis grower said Irina Hossu will join as its finance chief on March 29 this year, while the current CFO, Alex Dann, will remain until the end of March. Pure Gold Mining Inc (LON:PUR) (CVE:PGM) shares shined in London on Tuesday after the dual-listed Canadian miner hit high-grade gold intersections during exploration drilling at its Red Lake mine in Ontario. The company said the results suggested “strong mine continuity and the potential for mining stope expansion” and will be integrated into short-term mine planning. American Resources Corp. (NASDAQ:AREC), a supplier of raw materials to the steel industry, has struck up a partnership with Land Betterment LLC, a community development company that renovates former coal mining sites, in a bid to rehabilitate the Gold Star mine, its idled thermal coal mine in Green County, Indiana. Under the new partnership, Land Resources will take charge of selling scrap metal and other equipment at Gold Star. It will also provide environmental remediation services at the Indiana mining site to help American Resources repurpose parts of it for either alternative businesses or community use.  1933 Industries Inc. (CSE:TGIF) (OTCMKTS:TGIFF), a cannabis consumer packaged goods company, has hired PI Financial Corp and the Independent Trading Group for market-making services to comply with Canadian Securities Exchange policies. The companies will assist 1933 in maintaining its trading of securities in the market. In return for the services, the company will pay a monthly fee of C$4,000 to PI and C$7,500 to ITG for a three-month term and with an option to renew. Neither PI nor ITG will be granted shares or options as compensation. 1933 is a cannabis company with operations in the United States and Canada. Operating via three subsidiaries, 1933 owns licensed medical and recreational cannabis cultivation and production assets, hemp-based CBD infused products, CBD extraction services and a specialized cannabis advisory firm. Genprex Inc (NASDAQ:GNPX) announced Tuesday that it has closed on an at-the-market stock offering that raised $8 million. The gene therapy company sold 7.6 million shares at a price of $1.05 per share, in accordance with Nasdaq rules governing registered direct offerings. No warrants were issued in the offering.  Bay Talent Group's (CVE:HIRE) senior management, certain board members and other professional colleagues will ring the opening bell of the Toronto Stock Exchange on January 30. BTG began trading on the TSX Venture Exchange on December 23.. "We have dedicated the last two years to build this company to what it is today, a one-of-a-kind staffing consolidator with a focus on revenue-generating partnerships and digital innovation," said CEO Allan Hartley. "From day one, we have had a firm commitment to building long-term value and this milestone of becoming a public company is one of many to come. We are honoured to celebrate BTG's success with those who have supported our mission." mCloud Technologies Corp. (CVE:MCLD) (OTCMKTS:MCLDD), the AI and analytics specialist, has raised a further $1.831 million on a gross basis for working capital and furthering its business thanks to the completion of an additional tranche of its special warrant financing. The total gross proceeds generated by the entire offering amount to $13,331,500. In arranging the additional tranche, mCloud issued 457,875 special warrants at a price of $4 per warrant. The securities issued as part of the introduction of an additional tranche will likely be subject to a four-month hold period from the closing date and the offering remains subject to the approval of the TSX Venture Exchange. MCloud operates in the burgeoning world of artificial intelligence and the internet of Things. Its technology aims to curb energy waste and maximize energy production. Power Ore Inc (CVE:PORE) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement which will see the issue of three million shares at a purchase price of 5 cents per share, together with 1.5 million share purchase warrants at an exercise price of 7 cents for a two-year period with one placee.

Full Article